Phase 2 Recessive dystrophic epidermolysis bullosa Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
Recessive dystrophic epidermolysis bullosaEpidermolysis BullosaDystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich8 enrolled1 locationNCT06834035
Recruiting
Phase 1Phase 2
GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment
Recessive dystrophic epidermolysis bullosaEpidermolysis Bullosa Dystrophica, RecessiveRDEB
CHU de Quebec-Universite Laval9 enrolled1 locationNCT07193134
Completed
Phase 2
Investigation of cell therapy for recessive dystrophic epidermolysis bullosa (RDEB) in Australia through intradermal injection of allogeneic fibroblasts.
Recessive dystrophic epidermolysis bullosa
Research Infrastructure Support Services (RISS)5 enrolled1 locationACTRN12610000760077